BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15619248)

  • 1. Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug.
    Kossena GA; Charman WN; Boyd BJ; Porter CJ
    J Pharm Sci; 2005 Mar; 94(3):481-92. PubMed ID: 15619248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
    Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
    Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
    Yeap YY; Trevaskis NL; Quach T; Tso P; Charman WN; Porter CJ
    Mol Pharm; 2013 May; 10(5):1874-89. PubMed ID: 23480483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs.
    Yeap YY; Trevaskis NL; Porter CJ
    Mol Pharm; 2013 Jul; 10(7):2601-15. PubMed ID: 23697606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs.
    Kossena GA; Charman WN; Boyd BJ; Porter CJ
    J Control Release; 2004 Sep; 99(2):217-29. PubMed ID: 15380632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug.
    Lee KW; Porter CJ; Boyd BJ
    J Pharm Sci; 2013 Feb; 102(2):565-78. PubMed ID: 23242691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach.
    Kossena GA; Charman WN; Boyd BJ; Dunstan DE; Porter CJ
    J Pharm Sci; 2004 Feb; 93(2):332-48. PubMed ID: 14705191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Formation of Cubic Phase in Situ after Oral Administration of Cubic Phase Precursor Formulation Provides Long Duration Gastric Retention and Absorption for Poorly Water-Soluble Drugs.
    Pham AC; Hong L; Montagnat O; Nowell CJ; Nguyen TH; Boyd BJ
    Mol Pharm; 2016 Jan; 13(1):280-6. PubMed ID: 26567591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
    Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
    Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison across Three Hybrid Lipid-Based Drug Delivery Systems for Improving the Oral Absorption of the Poorly Water-Soluble Weak Base Cinnarizine.
    Joyce P; Yasmin R; Bhatt A; Boyd BJ; Pham A; Prestidge CA
    Mol Pharm; 2017 Nov; 14(11):4008-4018. PubMed ID: 28950059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Digestion-In Situ Absorption Setup Employing a Physiologically Relevant Value of the Membrane Surface Area/Volume Ratio for Evaluating Performance of Lipid-Based Formulations: A Comparative Study with an In Vitro Digestion-Permeation Model.
    Tanaka Y; Arai H; Hidaka A; Noda S; Imai K; Tsujisawa F; Yagi H; Sakuma S
    Mol Pharm; 2024 Jul; 21(7):3459-3470. PubMed ID: 38809159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-Based Formulations Can Enable the Model Poorly Water-Soluble Weakly Basic Drug Cinnarizine To Precipitate in an Amorphous-Salt Form During In Vitro Digestion.
    Khan J; Rades T; Boyd BJ
    Mol Pharm; 2016 Nov; 13(11):3783-3793. PubMed ID: 27631273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption of cinnarizine from type II lipid-based formulations: Impact of lipid chain length, supersaturation, digestion, and precipitation inhibition.
    Paulus F; Holm R; Stappaerts J; Bauer-Brandl A
    Eur J Pharm Sci; 2024 Jun; 197():106765. PubMed ID: 38608735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution or suspension - Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug.
    Larsen AT; Holm R; Müllertz A
    Eur J Pharm Biopharm; 2017 Aug; 117():308-314. PubMed ID: 28465239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate.
    Sassene PJ; Knopp MM; Hesselkilde JZ; Koradia V; Larsen A; Rades T; Müllertz A
    J Pharm Sci; 2010 Dec; 99(12):4982-91. PubMed ID: 20574997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs.
    Iwanaga K; Kushibiki T; Miyazaki M; Kakemi M
    Biol Pharm Bull; 2006 Mar; 29(3):508-12. PubMed ID: 16508155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
    Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
    Nguyen TH; Hanley T; Porter CJ; Boyd BJ
    J Control Release; 2011 Jul; 153(2):180-6. PubMed ID: 21497623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.